Unknown

Dataset Information

0

The CD33 splice isoform lacking exon 2 as therapeutic target in human acute myeloid leukemia.

ABSTRACT:

SUBMITTER: Godwin CD 

PROVIDER: S-EPMC7431376 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Targeting CD33 for acute myeloid leukemia therapy.
| S-EPMC8722076 | biostudies-literature
Unknown Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia.
| S-EPMC4498153 | biostudies-literature
Unknown Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33.
| S-EPMC6981622 | biostudies-literature
Unknown CD157: From Myeloid Cell Differentiation Marker to Therapeutic Target in Acute Myeloid Leukemia.
| S-EPMC6952987 | biostudies-literature
Unknown SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia.
| S-EPMC8410582 | biostudies-literature
Unknown Gemtuzumab ozogamicin for treatment of newly diagnosed CD33-positive acute myeloid leukemia.
| S-EPMC6331698 | biostudies-literature
Unknown Therapeutic Target Discovery Using High-Throughput Genetic Screens in Acute Myeloid Leukemia.
| S-EPMC7465943 | biostudies-literature
Unknown Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.
| S-EPMC4416943 | biostudies-literature
Unknown PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome.
| S-EPMC4551362 | biostudies-literature
Unknown Polo-like kinase inhibition as a therapeutic target in acute myeloid leukemia.
| S-EPMC8238245 | biostudies-literature